AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
Through the Patient ID Now coalition, AMIA along with over 150 healthcare organizations urge Congress to remove Section 510 from the FY2026 Labor-HHS Appropriations bill, which bans funding for a national unique patient identifier. This outdated provision hinders patient safety, contributes to medical errors, and causes costly inefficiencies—totaling over $6.7 […]
AMIA joined Coalition for Health Funding’s letter, signed by over 500 health and research organizations, strongly opposing the Administration’s draft FY 2026 budget proposal for the Department of Health and Human Services (HHS), which includes a one-third cut to discretionary funding. The coalition warns such cuts would severely harm the […]
On April 23, 2025, AMIA joined over 100 organizations urging Congress to allocate at least $1.7 billion for the Advanced Research Projects Agency for Health (ARPA-H) in FY 2026, emphasizing the importance of maintaining its independence within the Department of Health and Human Services. ARPA-H, modeled after DARPA, has initiated […]
AMIA raised concerns about the evidence behind the HHS reorganization decisions and questions the exclusion of the Assistant Secretary for Technology Policy/Office of the National Coordinator of Health IT (ASTP). It highlights the importance of ASTP in securing patient data and supporting clinical care. AMIA also questioned the potential move […]
AMIA responded to the FDA's draft guidance on "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations." We commended the FDA for its comprehensive approach to ensuring the safe and effective use of AI-enabled devices in healthcare. The comment letter emphasized the importance of transparency, bias control, and […]
AMIA responded to the House Committee on Energy and Commerce's Request for Information (RFI) on data privacy and security framework. The comment letter emphasized the need for a comprehensive data privacy and security law that includes clear definitions of personal and sensitive personal information. AMIA advocated for transparency in data […]
AMIA joined the Disability & Rehabilitation Research Coalition (DRRC), comprising 28 national organizations, commended the National Institutes of Health (NIH) for its draft Strategic Plan for Disability Health Research for FY26-FY30. The DRRC emphasized the critical need for biomedical, functional, and outcomes research to support the approximately 70 million adults […]
AMIA submitted recommendations for the U.S. AI Action Plan, emphasizing the importance of integrating AI responsibly within healthcare. Key principles include ensuring transparency about AI tools' purposes and data usage, establishing rigorous validation and continuous monitoring to maintain safety and effectiveness, reducing administrative burdens on providers through AI applications, and […]
The Friends of ASTP have formally introduced the coalition to HHS Secretary Robert F. Kennedy Jr. In our letter, we emphasize ASTP's pivotal role in advancing health IT, interoperability, and AI-driven healthcare. The coalition seeks a meeting with Secretary Kennedy to discuss collaborative opportunities aimed at enhancing healthcare delivery and […]
The letter, endorsed by over 600 organizations including AMIA, urges Congress to allocate at least a $1.77 billion increase for the National Institutes of Health (NIH) in the Fiscal Year 2025 appropriations bill.
It emphasizes the necessity of preserving existing protections against cuts to reimbursement for NIH grantee Facilities and […]